The results of this study demonstrate that both AFP and PIVKA-II have independent diagnostic value in the detection of HCC among patients with chronic hepatitis B and C. Importantly, the combined use of these two biomarkers yielded superior predictive accuracy compared with either marker alone, consistently across both etiological cohorts. This evidence concerns the gene AFP and chronic hepatitis B virus infection.